FDA
U.S. Food and Drug Administration — The U.S. regulator that approves drugs, medical devices, and food safety.
Coverage of FDA is rising : 51 signals on the latest tracked day, up 143% from its three-week baseline of 21, across 10 domains (up from 6 a week ago). That makes it the #16 most-covered of the 274 concerns we track.
If FDA matters to your work, coverage is climbing off its baseline — worth a closer-than-usual look this week.
What’s changed
7 of the last 7 tracked days ran above the three-week baseline — a sustained move, not a one-day spike.
- Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments · STAT · 2026-08-07
- STAT+: Two FDA approvals — a new drug and a new vaccine · STAT News — All Content · 2026-08-07
- STAT+: FDA approves Replimune melanoma drug previously rejected twice · STAT News — All Content · 2026-08-07
- Replimune rebounds to win FDA approval of melanoma drug · BioPharma Dive — Latest News · 2026-08-07
- Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA · Reddit r/biotech · 2026-08-07
- Walter Reed’s 3D Printed Titanium Cranial Plate Becomes First Implant Cleared by the FDA for a Point-of-Care Institution · 3D Printing Industry · 2026-08-07 · usually covers Additive Manufacturing
What the reporting says
Across 711 tracked stories from 52 outlets, reporting on FDA most often describes regulatory approvals (408), IPOs or listings (6), military action (5), launches or releases (4), acquisition (4), meetings or visits (4).
It shows up alongside GLP-1 (17), Eli Lilly (24), Immunotherapy (39), United States (39), Colorectal Cancer (37), Merck (16), Pfizer (14), AI (24).
Two steps out: China (through United States, 39 shared stories on the weaker link); Hormuz (through United States, 39 shared stories on the weaker link); Iran (through United States, 39 shared stories on the weaker link); Israel (through United States, 39 shared stories on the weaker link).
Tracked since Apr 6, with coverage on 94 separate days — concentrated in Pharma Regulatory and Biotech Pharma.